Gallacher Capital Management’s Pfizer PFE Stock Holding History

Gallacher Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-7,424	Closed	-$246K	–	292
2023 Q3	$246K	Sell	7,424 -6,289	-46%	-$222K	0.15%	185
2023 Q2	$503K	Buy	13,713 +8,200	+149%	+$319K	0.29%	79
2023 Q1	$225K	Buy	5,513 +328	+6%	+$14.2K	0.13%	210
2022 Q4	$266K	Buy	+5,185	New	+$249K	0.16%	161

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Gallacher Capital Management's PFE Position: Q4 2023 in Review

Gallacher Capital Management sold out of Pfizer (PFE) in Q4 2023, closing a stake of 7,424 shares — an estimated $246K sold.

Gallacher Capital Management first reported a position in PFE in Q4 2022 and held it in 4 quarters. The position peaked at $503K in Q2 2023. 2,936 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

Gallacher Capital Management reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
Gallacher Capital Management sold 7,424 Pfizer shares in Q4 2023, an estimated $246K.
Gallacher Capital Management first reported a position in Pfizer in Q4 2022 and held it in 4 quarters.
Gallacher Capital Management's Pfizer position peaked at $503K in Q2 2023.
2,936 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Gallacher Capital Management's 13F filing for Q4 2023, filed 6 Feb 2024.